Market Overview - A-shares experienced narrow fluctuations with the pharmaceutical and liquor sectors collectively rising [1] - The Shanghai Composite Index rose by 0.3%, the Shenzhen Component Index increased by 0.3%, and the ChiNext Index gained 0.39% [1] Pharmaceutical Sector - The pharmaceutical sector saw significant gains, with stocks like Shenlian Bio and Boji Medicine rising sharply [4] - Shenlian Bio increased by 20.03% to 15.40, while Boji Medicine rose by 19.98% to 13.15 [6] - A total of 534 drug names passed the preliminary review for the national basic medical insurance directory, a notable increase from last year [7] - The continuous optimization of the medical insurance directory adjustment mechanism is expected to stimulate innovation in the pharmaceutical industry [7] OCS Optical Switch Concept - The OCS optical switch concept has shown strong performance, with stocks like Tengjing Technology and Dekeli hitting the daily limit and continuing to rise [3] - OCS allows direct routing and switching of optical signals without converting to electrical signals, with significant demand expected from Google [3] - By 2026, the market size for OCS is projected to reach $4 billion, driven by increasing demand from major manufacturers [3] Investment Opportunities in Innovative Drugs - Investment recommendations focus on three main lines: overseas expansion of innovative drugs, high-growth CXO (contract research and manufacturing services) leaders, and the revaluation of pipeline values for Big Pharma [8] - Upcoming academic conferences are expected to catalyze further developments in the innovative drug sector [7]
A股两大猜想!今天盘中 实现了一个
Zhong Guo Zheng Quan Bao·2025-08-19 04:52